Jan 4 (Reuters) - PIXIUM VISION SA:
* PIXIUM VISION RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN THE US
* RECEIVES FDA APPROVAL TO BEGIN HUMAN CLINICAL STUDY OF ITS PRIMA SUB-RETINAL IMPLANT IN US
* FEASIBILITY CLINICAL STUDY IS DESIGNED TO EVALUATE PRIMA IN PATIENTS WITH ATROPHIC DRY AGE-RELATED MACULAR DEGENERATION
* EXPECTS TO START US STUDY IN FIRST HALF OF 2018. Source text for Eikon: Further company coverage: (Gdynia Newsroom:)
Our Standards: The Thomson Reuters Trust Principles.